ALKERMES | ALKS - Trade Debtors


ALKERMES reported $355.11M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.64B 160M Jun/2025
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
ALKERMES USD 355.11M 1.22M Sep/2025
Amgen USD 8.49B 211M Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 5.1B 314M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
J&J USD 17.61B 235M Sep/2025
Malin Corporation EUR 500K 300K Dec/2024
Merck USD 12.12B 596M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Otsuka Holdings JPY 530.36B 25.95B Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025